WASHINGTON, DC - With medical innovations on the rise, there’s plenty of reason for patients and their loved ones to have hope for new treatments and cures. The FDA Reauthorization Act (FDARA) of 2017 will boost these innovations, delivering for patients and manufacturers.
Watch the videos below to learn more about FDARA.
All too often, our laws and regulations don’t allow medical advancements to be implemented soon enough. FDARA will help these important innovations reach patients sooner and increase competition in the marketplace.
More than two million Americans work in the medical device sector and more than 4 million Americans work in the biopharmaceutical industry. These are important jobs that we need to keep - and grow - here at home.
FDARA improves the process of reviewing and approving innovative new drugs, which increases competition and helps lower costs across the marketplace.
Anything is possible with today’s medical advancements. From the idea of an artificial pancreas to reality, FDARA boosts these important efforts enabling patients to live better and healthier lives.
#SubHealth announced yesterday that it will markup FDARA tomorrow at 10 a.m.
